메뉴 건너뛰기




Volumn 29, Issue 2, 2009, Pages 737-744

Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1

Author keywords

Germ cell tumors; Immunohistochemical markers; MIB 1; p53; Prognostic markers; Survival

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; IFOSFAMIDE; KI 67 ANTIGEN; METHOTREXATE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STEM CELL FACTOR; TOPOISOMERASE IIA; TUMOR MARKER; UNCLASSIFIED DRUG; VINBLASTINE;

EID: 61449100668     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (11)

References (34)
  • 1
    • 0030857028 scopus 로고    scopus 로고
    • Testicular germ-cell cancer
    • Bosl GJ and Motzer RJ: Testicular germ-cell cancer. N Engl J Med 337: 242-253, 1997.
    • (1997) N Engl J Med , vol.337 , pp. 242-253
    • Bosl, G.J.1    Motzer, R.J.2
  • 3
    • 23944440892 scopus 로고    scopus 로고
    • Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors
    • Farmakis D, Pectasides M and Pectasides D: Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors. Eur Urol 48: 400-407, 2005.
    • (2005) Eur Urol , vol.48 , pp. 400-407
    • Farmakis, D.1    Pectasides, M.2    Pectasides, D.3
  • 4
    • 0031037241 scopus 로고    scopus 로고
    • A prognostic factor-based staging system for metastatic germ cell cancers
    • International Germ Cell Consensus Classification IGCCC
    • International Germ Cell Consensus Classification (IGCCC): A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15: 594-603, 1997.
    • (1997) J Clin Oncol , vol.15 , pp. 594-603
  • 5
    • 34548093252 scopus 로고    scopus 로고
    • The management of stage I nonseminomatous testicular germ cell tumors
    • Pectasides D, Farmakis D and Pectasides M: The management of stage I nonseminomatous testicular germ cell tumors. Oncology 71: 151-158, 2006.
    • (2006) Oncology , vol.71 , pp. 151-158
    • Pectasides, D.1    Farmakis, D.2    Pectasides, M.3
  • 6
    • 0031466945 scopus 로고    scopus 로고
    • Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines
    • Burger H, Nooter K, Boersma AW, Kortland CJ and Stoter G: Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines. Int J Cancer 73: 592-599, 1997.
    • (1997) Int J Cancer , vol.73 , pp. 592-599
    • Burger, H.1    Nooter, K.2    Boersma, A.W.3    Kortland, C.J.4    Stoter, G.5
  • 7
    • 0030977823 scopus 로고    scopus 로고
    • MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis
    • Albers P, Bierhoff E, Neu D, Fimmers R, Wernert N and Müller SC: MIB-1 immunohistochemistry in clinical stage I nonseminomatous testicular germ cell tumors predicts patients at low risk for metastasis. Cancer 79: 1710-1716, 1997.
    • (1997) Cancer , vol.79 , pp. 1710-1716
    • Albers, P.1    Bierhoff, E.2    Neu, D.3    Fimmers, R.4    Wernert, N.5    Müller, S.C.6
  • 8
    • 0032169646 scopus 로고    scopus 로고
    • Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis
    • Heidenreich A, Sesterhenn IA, Mostofi FK and Moul JW: Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 83: 1002-1011, 1998.
    • (1998) Cancer , vol.83 , pp. 1002-1011
    • Heidenreich, A.1    Sesterhenn, I.A.2    Mostofi, F.K.3    Moul, J.W.4
  • 10
    • 0035009052 scopus 로고    scopus 로고
    • Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas
    • Koshiyama M, Fujii H, Kinezaki M and Yoshida M: Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas. Anticancer Res 21: 905-910, 2001.
    • (2001) Anticancer Res , vol.21 , pp. 905-910
    • Koshiyama, M.1    Fujii, H.2    Kinezaki, M.3    Yoshida, M.4
  • 11
    • 34247618746 scopus 로고    scopus 로고
    • Topoisomerase II alpha expression in testicular germ cell tumors
    • Dimov ND, Zynger DL, Luan C, Kozlowski JM and Yang XJ: Topoisomerase II alpha expression in testicular germ cell tumors. Urology 69: 955-961, 2007.
    • (2007) Urology , vol.69 , pp. 955-961
    • Dimov, N.D.1    Zynger, D.L.2    Luan, C.3    Kozlowski, J.M.4    Yang, X.J.5
  • 13
    • 0003486931 scopus 로고
    • World Health Organization:, WHO Offset Publication No 48, Geneva, Switzerland: World Health Organization
    • World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment (WHO Offset Publication No 48). Geneva, Switzerland: World Health Organization, 1979.
    • (1979) WHO Handbook for Reporting Results of Cancer Treatment
  • 14
    • 0344872710 scopus 로고    scopus 로고
    • Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: A HECOG trial
    • Pectasides D, Skarlos D, Dimopoulos AM, Farmakis D, Pectasides M, Fountzilas G and Aravantinos G: Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial. Anticancer Res 23: 4239-4244, 2003.
    • (2003) Anticancer Res , vol.23 , pp. 4239-4244
    • Pectasides, D.1    Skarlos, D.2    Dimopoulos, A.M.3    Farmakis, D.4    Pectasides, M.5    Fountzilas, G.6    Aravantinos, G.7
  • 19
    • 0037048311 scopus 로고    scopus 로고
    • DNA topoisomerase I and II expression in drug-resistant germ cell tumours
    • Berney DM, Shamash J, Gaffney J, Jordan S and Oliver RT: DNA topoisomerase I and II expression in drug-resistant germ cell tumours. Br J Cancer 87: 624-629, 2002.
    • (2002) Br J Cancer , vol.87 , pp. 624-629
    • Berney, D.M.1    Shamash, J.2    Gaffney, J.3    Jordan, S.4    Oliver, R.T.5
  • 21
    • 0032983371 scopus 로고    scopus 로고
    • Activating c-kit gene mutations in human germ cell tumors
    • Tian Q, Frierson J HF, Krystal GW and Moskaluk CA: Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 154: 1643-1647, 1999.
    • (1999) Am J Pathol , vol.154 , pp. 1643-1647
    • Tian, Q.1    Frierson, J.H.2    Krystal, G.W.3    Moskaluk, C.A.4
  • 23
    • 0029929672 scopus 로고    scopus 로고
    • Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio
    • Chresta CM, Masters JR and Hickman JA: Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56: 1834-1841, 1996.
    • (1996) Cancer Res , vol.56 , pp. 1834-1841
    • Chresta, C.M.1    Masters, J.R.2    Hickman, J.A.3
  • 25
    • 0042130382 scopus 로고    scopus 로고
    • Cluster analysis of p53 and Ki-67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor
    • Mazumdar M, Bacik J, Tickoo SK, Dobrzynski D, Donadio A, Bajorin D, Motzer R, Reuter V and Bosl GJ: Cluster analysis of p53 and Ki-67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor. J Clin Oncol 21: 2679-2688, 2003.
    • (2003) J Clin Oncol , vol.21 , pp. 2679-2688
    • Mazumdar, M.1    Bacik, J.2    Tickoo, S.K.3    Dobrzynski, D.4    Donadio, A.5    Bajorin, D.6    Motzer, R.7    Reuter, V.8    Bosl, G.J.9
  • 26
    • 0035942493 scopus 로고    scopus 로고
    • A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells
    • Lutzker SG, Mathew R and Taller DR: A p53 dose-response relationship for sensitivity to DNA damage in isogenic teratocarcinoma cells. Oncogene 20: 2982-2986, 2001.
    • (2001) Oncogene , vol.20 , pp. 2982-2986
    • Lutzker, S.G.1    Mathew, R.2    Taller, D.R.3
  • 29
    • 26944495365 scopus 로고    scopus 로고
    • A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma
    • Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J and Spinella MJ: A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene 24: 6090-6100, 2005.
    • (2005) Oncogene , vol.24 , pp. 6090-6100
    • Kerley-Hamilton, J.S.1    Pike, A.M.2    Li, N.3    DiRenzo, J.4    Spinella, M.J.5
  • 30
    • 34748915836 scopus 로고    scopus 로고
    • Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles
    • Duale N, Lindeman B, Komada M, Olsen AK, Andreassen A, Soderlund EJ and Brunborg G: Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Mol Cancer 6: 53, 2007.
    • (2007) Mol Cancer , vol.6 , pp. 53
    • Duale, N.1    Lindeman, B.2    Komada, M.3    Olsen, A.K.4    Andreassen, A.5    Soderlund, E.J.6    Brunborg, G.7
  • 33
    • 0032771490 scopus 로고    scopus 로고
    • Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer
    • Dingemans AM, Witlox MA, Stallaert RA, van der Valk P, Postmus PE and Giaccone G: Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer. Clin Cancer Res 5: 2048-2058, 1999.
    • (1999) Clin Cancer Res , vol.5 , pp. 2048-2058
    • Dingemans, A.M.1    Witlox, M.A.2    Stallaert, R.A.3    van der Valk, P.4    Postmus, P.E.5    Giaccone, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.